Lara MottCEO, ImproveWell


Lara is Director of Investor Relations at GHO Capital Partners LLP, a specialist healthcare investment adviser. She was most recently Vice President, Corporate Affairs at Circassia Pharmaceuticals plc where she was recruited to support the largest UK biopharmaceutical fundraising at IPO. Prior to this, Lara has held senior in-house roles including Head of Investor Relations and Corporate Communications at Oxford BioMedica plc and Investor Relations Manager at Apax Partners.

Before joining Apax, Lara was a Consultant in the Life Sciences and Healthcare team at FTI Consulting and started her career as an analyst at Höegh Capital Partners Advisors Ltd. A life sciences specialist, she holds a first class degree in Pharmacology from the University of Bristol where she was awarded the Hans Heller Memorial Prize for outstanding performance. Lara is currently Deputy Chair of the UK BioIndustry Association’s Communications Advisory Committee.